MAP2K1 and melanoma: In our study, Class II and III MAP2K1-driven tumours exhibited spitzoid histomorphology in all nevi and three-quarters of melanocytomas and melanomas, compared to half of the tumours with Class I MAP2K1 mutations and concomitant MAPK mutations.